File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A step forward to the era of immunotherapy in resectable esophageal cancer: 2021 NCC/CATS/CSTCVS/STM expert consensus on perioperative immunotherapy for esophageal cancer

TitleA step forward to the era of immunotherapy in resectable esophageal cancer: 2021 NCC/CATS/CSTCVS/STM expert consensus on perioperative immunotherapy for esophageal cancer
Authors
Lam, Ka OnHiok, Lok YeeLaw, Simon
Issue Date25-Feb-2022
PublisherAME Publishing Company
Citation
Annals of Esophagus, 2022, v. 6 How to Cite?
DOI: http://dx.doi.org/10.21037/aoe-22-4
Persistent Identifierhttp://hdl.handle.net/10722/354756
ISSN
2616-2784
2023 SCImago Journal Rankings: 0.313

 

DC FieldValueLanguage
dc.contributor.authorLam, Ka On-
dc.contributor.authorHiok, Lok Yee-
dc.contributor.authorLaw, Simon-
dc.date.accessioned2025-03-08T00:35:05Z-
dc.date.available2025-03-08T00:35:05Z-
dc.date.issued2022-02-25-
dc.identifier.citationAnnals of Esophagus, 2022, v. 6-
dc.identifier.issn2616-2784-
dc.identifier.urihttp://hdl.handle.net/10722/354756-
dc.languageeng-
dc.publisherAME Publishing Company-
dc.relation.ispartofAnnals of Esophagus-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleA step forward to the era of immunotherapy in resectable esophageal cancer: 2021 NCC/CATS/CSTCVS/STM expert consensus on perioperative immunotherapy for esophageal cancer-
dc.typeArticle-
dc.identifier.doi10.21037/aoe-22-4-
dc.identifier.scopuseid_2-s2.0-85153951246-
dc.identifier.volume6-
dc.identifier.eissn2616-2784-
dc.identifier.issnl2616-2784-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats